Allocated 1,000 paid stock acquisition rights to seven directors; underlying shares are 100,000 ordinary shares; total number of rights is 1,000; resolution date is 2026-09-29.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7371","jir_company_name":"Zenken Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7371-20261028-03.pdf","jir_short_summary":"Allocated 1,000 paid stock acquisition rights to seven directors; underlying shares are 100,000 ordinary shares; total number of rights is 1,000; resolution date is 2026-09-29.","jir_summary":"### Overview\nZenken Corporation has finalized previously undecided matters regarding the issuance of paid stock acquisition rights to directors, and resolved to allocate 1,000 rights to seven directors. The underlying shares are 100,000 ordinary shares, and the total number of rights is 1,000. The decision date is 2026-09-29.\n\n### Impact on Shareholders and Future Developments\nThis issuance is a stock option transaction and may create potential dilution risk upon exercise of the rights. The allocation is implemented as part of remuneration and incentives for directors, and the actual impact will depend on future exercise behavior and share price movements. Additional terms and the schedule related to this matter are expected to be disclosed in subsequent IR releases.","jir_financial_highlights":"Total number of stock acquisition rights: 1,000 pieces (Unknown)\nType and number of underlying shares: Ordinary shares 100,000 shares (Unknown)\nAllottees: Company directors 7 people (Unknown)","jir_category":"","jir_hashtags":"#Zenken, #StockOptionIssuance, #PaidStockAcquisitionRights","jir_key_figures":"Total number of stock acquisition rights: 1,000 pieces\nUnderlying shares: Ordinary shares 100,000 shares\nAllottees: Directors 7 people","jir_meta_title":"Zenken Corporation \u2014 Notice on Finalization of Terms for Issuance of Stock Acquisition Rights | October 2026","jir_meta_description":"Zenken Corporation has resolved to allocate 1,000 paid stock acquisition rights to seven directors. Underlying shares total 100,000 ordinary shares; decision date: 2026-09-29. Monitor future exercise status and potential dilution risk.","jir_og_title":"Zenken Corporation \u2014 Notice on Finalization of Terms for Issuance of Stock Acquisition Rights","jir_og_description":"Zenken Corporation will allocate 1,000 paid stock acquisition rights to seven directors. Total rights: 1,000; underlying shares: 100,000 ordinary shares. Decision date: 2026-09-29.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":122848,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-135540","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n